Pamela M. McMahon

Also affiliated with Harvard Pilgrim Health Care

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Population-Based Newborn Screening for Germline TP53 Variants: Clinical Benefits, Cost-Effectiveness, and Value of Further Research”.

Population-Based Newborn Screening for Germline TP53 Variants: Clinical Benefits, Cost-Effectiveness, and Value of Further Research

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac013

N/A

0DataRank · unranked

10 citations

Natasha K. Stout, Grace O’Brien, Kurt D. Christensen, Pamela M. McMahon, Ann Chen Wu +3 more

Benefits, harms, and costs of newborn genetic screening for hypertrophic cardiomyopathy: Estimates from the PreEMPT model

Genetics in Medicine(2023)10.1016/j.gim.2023.100797

N/A

0DataRank · unranked

7 citations

Pamela M. McMahon, Lauren N. Galbraith, Jennifer M. Yeh, Natasha K. Stout, Christine Y. Lu +5 more